Views
11 months ago

GSN Magazine June 2016 Digital Edition

Winners’ Portraits:

Winners’ Portraits: GSN 2016 Airport, Seaport, Border Security Awa Implant Sciences: 2016 Winner, Best Explosives Detection Solution By Adrian Courtenay June 24, 2016 – As airports and nations around the globe become more concerned with every new act of terrorism, the U.S. Department of Homeland Security’s Transportation Security Administration (TSA) has committed tens of millions of dollars to an explosive trace detection (ETD) product: the Implant Sciences QS-B220. The TSA, considered the leading ETD evaluation agency in the world, qualified the QS-B220 for passenger and baggage screening in August of 2014. Shortly thereafter, the product became the first to pass Europeas stringent laboratory testing protocol in October 2014. Since that time, the TSA has awarded Implant Sciences an exclusive ID/IQ (basically an open purchase order) for $162 million, followed by an order for 1,170 units. These units are being installed right now. In Europe, the QSB220 has been deployed at airports in The Netherlands, France, Germany, Belgium, Norway, Austria, the Czech Republic, Romania, Cyprus and Poland. Among the many reasons for this overwhelming leadership, according to Dr. Darryl Jones, Executive Vice President of Implant Sciences, “the QS-B220 provides fast, accurate real-time detection of trace amounts of a wide variety of military, commercial and homemade explosives, as well as drugs. Featuring a low total cost of ownership , the system is easy to use, with intuitive controls that eliminate or reduce training requirements. “A patented automatic internal calibration system simplifies operations of the system and minimizes the need for manual calibration using costly consumables – and its small footprint is well suited to crowded security checkpoints. Unlike some competing systems, its low false alarm rate keeps airport operators on track. Furthermore, fewer false alarms means faster passenger through-put at checkpoints and fewer distractions for screening personnel. “ According to President Robert Liscouski, a regular commentator on CNN, Fox News and other business and security media, who was 36 appointed by President George W. Bush as the first Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security, “Implant Sciences continues to innovate, earning its 19th patent, which significantly enhances the company’s non-contact sampling capability, making it an ideal tool for next generation ETD technology. In fact,” said Liscouski, “we have been awarded a developmental contract worth up to $2 million by the Department of Homeland Security to develop advanced ETD solutions. That contract is set to commence shortly.” Implant Sciences Markets As a leading manufacturer of explosive trace detection (ETD) and drugs trade detection solutions for homeland security applications, Implant Sciences products meet the needs of a wide variety of security venues: AVIATION The QS-B220 desktop ETD is the first product of its kind without radioactive materials to pass testing with both Transportation Security

ds Program Administration (TSA) and the European Civil Aviation Conference (ECAC), and has been selected for deployment in a number of major international airports globally. The company is dedicated to improving overall passenger experience while increasing screening efficiency and augmenting security. CARGO The QS-B220 is on the Qualified Products list in the TSA’s Air Cargo Screening Technology List (ACSTL) and was the first system to pass the ECAC Common Evaluation Process (CEP) for cargo. With sample results in 10 seconds more or less and a fast clear-down, the system allows freight forwarders and cargo screeners to clear shipments more quickly. CRITICAL INFRASTRUCTURE A wide range of critical infrastructure facilities rely on Implant Sciences to help protect them against terrorist attacks. Installations include nuclear power plants, oil and gas facilities, banks, embassies and other high-threat infrastructure. CUSTOMS AND BORDERS Able to detect a wide variety of illegal drugs, including synthetics such as Spice and Molly, as well as explosives, the desktop QS-B220 is an excellent tool for customs and borders. MILITARY AND FIRST RESPONSE Working in the even the most challenging of environments, the portable QS-H150 delivers performance and increases safety for those on the front lines. With one handed operation and minimal supply requirements, the system is extremely well-suited to field operations. For checkpoint applications, the TSAqualified QS-B220 provides the highest levels of detection. Here are the bios of four of the company leaders and management team who have contributed mightily to the company’s ongoing and growing success: DR. BILL McGANN, CHIEF EXECUTIVE OFFCER Dr. McGann, one of the original developers of commercial ion mobility spectrometry technology for explosives trace detection (ETD), joined Implant Sciences in April, 2012. He has authored over 70 research proposals to the U.S. Government, 20-plus 37 scientific publications and over 25 patents in the areas of nuclear, chemical and biological detection technologies. He played a key role in creating an industry around ETD science and technology at Ion Track Instruments, which was acquired by General Electric. After the acquisition, Dr. McCann served as Vice- President, R&D at GE Ion Track and went on to become Chief Technology Officer of GE Security. Immediately prior to joining Implant Sciences, he was VP Engineering for Global Fire Products and United Technologies. ROBERT LISCOUSKI, PRESIDENT Mr. Liscouski is a recognized security and counterterrorism expert with more than 30 years of experience as a senior government official, business leader, entrepreneur, special agent and law enforcement officer. After his appointment by President George W. Bush in 2003 as first Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security, he worked closely with the White House and other federal agencies